Mauro Stocchi Buys Shares of Stevanato Group

Mauro Stocchi, the Chief Business Strategy Officer of Stevanato Group S.p.A. (NYSE:STVN), recently purchased 6,586 shares of the company. The transaction took place on June 9, 2026, although the details about the price and total value of the purchase were not disclosed.

Other Institutional Activity in Stevanato Group

Conestoga Capital Advisors, LLC increased its holdings in Stevanato Group by 602,050 shares, bringing its total to 8,491,751 shares valued at about $116.76 million. Neuberger Berman Group LLC reduced its stake by 312,219 shares, ending with 4,475,492 shares worth approximately $61.54 million. TimesSquare Capital Management, LLC slightly trimmed its position by 10,605 shares, holding 3,489,716 shares valued at $47.98 million. T. Rowe Price Investment Management, Inc. cut its holdings by 698,724 shares, leaving it with 3,224,908 shares worth around $44.34 million. Meanwhile, Bamco Inc /NY/ added 498,714 shares, raising its total to 2,500,438 shares valued at $34.38 million.

Stevanato Group S.p.A. Stock Down 12.6%

Shares of Stevanato Group (NYSE:STVN) traded near $18.39 on Friday. The company boasts a market capitalization of approximately $5.02 billion and has a P/E ratio of 31.71, with a forward P/E of 21.95. The stock's 52-week range is between $12.89 and $28.00. It has a 50-day moving average of $17.39 and a 200-day moving average of $19.57. Stevanato Group's beta is 0.776, indicating lower volatility compared to the market.

Recent Earnings

In its latest earnings report, Stevanato Group reported revenue of about $1.20 billion, with a revenue growth rate of 6.6%. The company's net margin stood at 11.75%, and it achieved a return on equity of 9.59%. Earnings per share (EPS) were reported at $0.58. The next earnings release is scheduled for May 7, 2026.

Dividend

Stevanato Group offers an annual dividend rate of $0.06, yielding 0.34%. The dividend payout ratio is relatively low at 10.59%.

Insider Buying and Selling at Stevanato Group S.p.A.

In addition to Mauro Stocchi's recent purchase, other insiders have been active as well. On June 12, 2026, William Federici bought 4,975 shares, and Marco Dal Lago, the Chief Financial Officer, acquired 2,356 shares. On June 15, 2026, several insiders, including Karen Flynn, William Federici, Madhavan Balachandran, and Donald Morel Jr., sold 1,493 shares each at an average price of $17.09.

Analysts Set New Price Targets

Analysts have been active with their ratings for Stevanato Group. On June 16, 2026, TD Cowen initiated coverage with a 'buy' rating and a price target of $25. On June 2, 2026, Wolfe Research assumed coverage with a 'buy' rating and a target of $21. The stock has a consensus 'buy' recommendation with a mean target price of $24.45 across 10 analyst opinions.

About Stevanato Group

Stevanato Group S.p.A. designs, produces, and distributes products for the biopharmaceutical and healthcare industries globally. Headquartered in Piombino Dese, Italy, the company operates through segments that include Biopharmaceutical and Diagnostic Solutions and Engineering. It offers a range of products such as pre-fillable syringes, vials, and diagnostic solutions, serving clients in pharmaceuticals, biotechnology, and life sciences. Founded in 1949, the company is led by CEO Franco Stevanato and employs over 6,000 people.

Bottom Line

Mauro Stocchi's recent share purchase highlights insider interest in Stevanato Group. Investors often track insider transactions for potential insights into company prospects. The stock's recent performance and analyst ratings suggest a positive outlook, though these backward-looking transactions are not predictive of future performance.